Milestone Pharmaceuticals Inc (MIST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,519 | -29,156 | -19,717 | -10,354 | -59,685 |
| Depreciation Amortization | 105 | 79 | 54 | N/A | 92 |
| Other Working Capital | 3,656 | 437 | 229 | -899 | 1,243 |
| Other Operating Activity | 8,910 | 6,635 | 4,447 | 2,319 | 11,926 |
| Operating Cash Flow | $-28,848 | $-22,005 | $-14,987 | $-8,934 | $-46,424 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,316 | -11,040 | -17,525 | -27,014 | 4,868 |
| PPE Investments | -33 | -11 | -7 | N/A | -112 |
| Investing Cash Flow | $8,283 | $-11,051 | $-17,532 | $-27,014 | $4,756 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 50,000 |
| Common Stock Issued | 32,119 | 32,095 | 32,021 | 32,319 | 574 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -2,782 |
| Financing Cash Flow | $32,119 | $32,095 | $32,021 | $32,319 | $47,792 |
| Beginning Cash Position | 13,760 | 13,760 | 13,760 | 13,760 | 7,636 |
| End Cash Position | 25,314 | 12,799 | 13,262 | 10,131 | 13,760 |
| Net Cash Flow | $11,554 | $-961 | $-498 | $-3,629 | $6,124 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,848 | -22,005 | -14,987 | -8,934 | -46,424 |
| Capital Expenditure | -33 | -11 | -7 | N/A | -112 |
| Free Cash Flow | -28,881 | -22,016 | -14,994 | -8,934 | -46,536 |